Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Cardiac Pathways

This article was originally published in The Gray Sheet

Executive Summary

Cardiac Pathways: Receives investigational device exemption from FDA for its Arrythmia Mapping System cardiac ablation product for the treatment of tachyarrhythmias in the right atrium. Trials of the system, which utilizes Cardiac Pathways' 64-electrode Mercator "basket" mapping catheter, will take place at five U.S. sites and compare the AMS to other "commercially available mapping catheters." The Sunnyvale, California firm received IDE approval in February for use of the system in the left ventricle ("The Gray Sheet" Feb. 12, In Brief)...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts